ClearPoint Neuro Inc.

NASDAQ: CLPT · Real-Time Price · USD
11.63
-0.05 (-0.43%)
At close: Aug 15, 2025, 3:15 PM

ClearPoint Neuro Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-18.91M -22.09M -16.43M -14.41M
Depreciation & Amortization
1.9M 1.46M 777K 692K
Stock-Based Compensation
6.91M 6.08M 4.13M 2.08M
Other Working Capital
-1.24M 851K -1.25M 165K
Other Non-Cash Items
-245K 1.19M -346K 425K
Deferred Income Tax
n/a n/a n/a 202K
Change in Working Capital
1.4M -356K -4.29M -1.68M
Operating Cash Flow
-8.95M -13.72M -16.17M -12.7M
Capital Expenditures
-275K -1.05M -1.15M -168K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -21.59M n/a
Sales Maturities Of Investments
n/a 10M 12M n/a
Other Investing Acitivies
n/a -334K -893K n/a
Investing Cash Flow
-275K 8.95M -10.74M -168K
Debt Repayment
-10M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
40K 506K 745K 90K
Financial Cash Flow
6.19M 296K 409K 46.88M
Net Cash Flow
-3.04M -4.47M -26.49M 34.01M
Free Cash Flow
-9.22M -14.77M -17.31M -12.87M